December 09, 2025

Study Identifies Rectal Bleeding as Key Predictor of Early-Onset Colorectal Cancer

In individuals younger than age 50 undergoing a colonoscopy, greater odds for having colorectal cancer were observed among those who presented with rectal bleeding, according to findings from a study ...

The ASCO Post

December 05, 2025

Primary Analysis Shows Survival Benefit With Bemarituzumab Plus Chemotherapy in Gastric or Gastroesophageal Junction Cancer

The addition of bemarituzumab, a first-in-class anti-FGFR2b antibody, to mFOLFOX6 chemotherapy significantly improved overall survival in patients with FGFR2b-overexpressing (≥ 10% tumor cell staining...

The ASCO Post

December 05, 2025

Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas

The addition of the PD-L1–targeting monoclonal antibody durvalumab to conventional perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a statistical...

The ASCO Post

December 05, 2025

Spectroscopy Uncovers Shared Oxidative Marker in Stored Fish Species

Autofluorescence analysis reveals a consistent FAD-linked signal across salmon, seabream, and amberjack during chilled storage

The Analytical Scientist

December 01, 2025

Reaching Everyone, Everywhere: Breaking Barriers in Hepatitis C Testing

As global funding declines, decentralized testing, telehealth, and community-based care are helping expand access to HCV diagnosis and treatment

The Pathologist

November 25, 2025

AGA unveils new clinical practice guideline for Crohn's disease

Of the 16 recommendations, the panel rated one as “strong,” nine as “conditional,” and six as “knowledge gaps.”

Conexiant

November 13, 2025

Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas

The addition of the PD-L1–targeting monoclonal antibody durvalumab to conventional perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a statistical...

The ASCO Post

November 11, 2025

Routine AI Assistance May Lead to Loss of Skills in Endoscopists, Study Shows

Budzyń et al.'s study raises concerns over the negative impact of AI on endoscopist skills in colonoscopy detection—an essential task in preventing colon cancer.

The ASCO Post

November 06, 2025

AGA issues updated guidance on HDV management

An AGA panel recommended universal HDV screening for all patients with chronic HBV infection.

Conexiant